Suárez-Castañón C, Modroño-Riaño G, Solís-Sánchez G. [Variability and suitability of anti-asmathic treatment in pediatric primary health care].
Aten Primaria 2016;
49:263-270. [PMID:
27825644 PMCID:
PMC6876049 DOI:
10.1016/j.aprim.2016.07.001]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2016] [Revised: 07/25/2016] [Accepted: 07/29/2016] [Indexed: 01/22/2023] Open
Abstract
OBJECTIVE
To analyse the use patterns and the characteristics of anti-asmathic prescriptions in pediatric primary health care.
DESIGN
Observational and retrospective study.
LOCATION
Pediatric primary health care, Asturias, Spain.
PARTICIPANTS
Drug prescriptions in respiratory diseases in children (<14years old) during 2011.
PRINCIPAL MEASUREMENTS
Data obtained from the billing database of the Regional Health Service of Asturias and analysed by sanitary district and primary health centres, calculating the number of DDD/1.000 children/day (DHD). Clinical records audit in 6 paediatric surgeries of sanitary district V to evaluate the suitability of the drug prescriptions to the current recommendations.
RESULTS
The main group were bronchodilators (17.14DHD) with predominance of the inhaled route (14DHD). We observe more use of inhaled corticoids (4.83DHD), with an important use of fluticasone. We considered un-suitable 94.3% oral bronchodilators, and >50% of mepiramine prescriptions. We registered off-label prescriptions, 17.8% of them were about oral salbutamol, being used in children <2years old.
CONCLUSIONS
The use of anti-asthmatic drugs in our region is high, maybe it's related to the asthma prevalence. We observed variability between sanitary districts and health centres. The prescription patterns are closed to the current recommendation, except in the case of oral bronchodilators.
Collapse